Type 1 Diabetes Mellitus in Saudi Arabia: A Soaring Epidemic

Asirvatham Alwin Robert1, Abdulrahman Al-Dawish2, Muhammad Mujammami3

  • 1Department of Endocrinology and Diabetes, Diabetes Treatment Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.

Insights

Type 1 diabetes mellitus (T1DM) is rising globally, especially in young children. This review examines T1DM in Saudi Arabia, highlighting a lack of research despite high incidence rates.

Area of Science:

  • Endocrinology
  • Pediatrics
  • Public Health

Background:

  • Type 1 diabetes mellitus (T1DM) affects 1 in 300 people globally, with incidence increasing by 3% annually.
  • Alarmingly, T1DM is increasingly diagnosed in infants as young as six months.
  • This necessitates tailored management strategies for young children with T1DM.

Purpose of the Study:

  • To review the current literature on Type 1 diabetes mellitus in Saudi Arabia.
  • To highlight the prevalence, incidence, and sociodemographic aspects of T1DM in the Saudi population.
  • To identify research gaps in T1DM management for children in Saudi Arabia.

Main Methods:

  • Literature review of published studies on T1DM in Saudi Arabia.
  • Analysis of data from the Diabetes Atlas (8th edition).
  • Synthesis of information on prevalence, incidence, and sociodemographic factors.

Main Results:

  • Saudi Arabia has 35,000 children and adolescents with T1DM.
  • The country ranks 8th globally in the number of T1DM patients and 4th in incidence rate (33.5 per 100,000).
  • There is a significant lack of research on T1DM in Saudi Arabia compared to developed nations.

Conclusions:

  • T1DM poses a significant challenge in Saudi Arabia, particularly for the pediatric population.
  • Urgent need for increased research on T1DM prevalence, incidence, and management in Saudi Arabia.
  • Further studies are crucial to develop effective T1DM management systems for children in the region.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.7K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
506
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K